CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Colorectal Cancer|Lung Cancer|Pancreatic Cancer
Interventions: DRUG: CI-1040
Sponsor: University of Alabama at Birmingham
Collaborators: National Cancer Institute (NCI)